<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">srjms</journal-id><journal-id journal-id-type="pubmed">SRJMS</journal-id><journal-id journal-id-type="publisher">SRJMS</journal-id><issn>2788-9483</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/srjms.2026.v06i01.002</article-id><title-group><article-title>The Association of Zonulin with Obesity and Metabolic Parameters in Polycystic Ovary Syndrome Compared to Healthy Women</article-title></title-group><abstract>Background:&amp;nbsp;Polycystic ovary syndrome (PCOS) is a common endocrine–metabolic disorder characterized by insulin resistance, obesity, and multiple metabolic disturbances. Zonulin, a physiological modulator of intestinal tight junctions, is considered a marker of increased intestinal permeability and has been implicated in systemic inflammation and metabolic dysfunction, suggesting a potential role in the pathophysiology of PCOS. Aim: To evaluate the association of serum zonulin with obesity and metabolic parameters in women with PCOS compared to healthy controls.&amp;nbsp; Methods: This case–control study included 90 women aged 20–40 years: 40 women with PCOS (18 obese and 22 non-obese) and 50 healthy ovulatory women. The study was conducted at the gynecological and infertility clinics, Azadi Teaching Hospital, Kirkuk. Serum zonulin levels were measured, and insulin resistance was assessed using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR). Results: Women with PCOS demonstrated significantly higher body mass index (BMI), waist circumference, luteinizing hormone (LH), LH/FSH ratio, free testosterone, triglycerides, low-density lipoprotein cholesterol (LDL-C), HOMA-IR, C-reactive protein (CRP), and zonulin levels compared with controls, while high-density lipoprotein cholesterol (HDL-C) was significantly lower. Obese women with PCOS exhibited significantly higher metabolic and hormonal parameters, including zonulin, compared with non-obese PCOS women. Serum zonulin levels were significantly elevated in PCOS patients compared to controls (49.3±12.5 vs 35.37±10.55 ng/mL, p&amp;lt;0.05). Zonulin showed positive correlations with BMI, waist circumference, HOMA-IR, triglycerides, total cholesterol, CRP, LH, and free testosterone, and a negative correlation with HDL-C. At a cut-off value of 40.63 ng/mL, zonulin demonstrated 70% sensitivity and 70% specificity (PPV 65%, NPV 74%). Conclusion: Serum zonulin levels are elevated in women with PCOS, particularly in obese women, and are associated with insulin resistance, inflammation, dyslipidemia, and hyperandrogenism. These findings support a potential role for zonulin in the metabolic and inflammatory pathophysiology of PCOS.</abstract></article-meta></front><body /><back /></article>